REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 14th, 2018 • Sunshine Biopharma, Inc • Services-commercial physical & biological research • Nevada
This REGISTRATION RIGHTS AGREEMENT (the “Agreement”), dated as of September 10, 2018 (the “Execution Date”), is entered into by and between Sunshine Biopharma Inc., a Colorado corporation with its principal executive office at 6500 Trans-Canada Highway, 4th Floor, Pointe-Claire, Quebec, Canada H9R 0A5 (the “Company”), and GHS Investments LLC, a Nevada limited liability company, with offices at 420 Jericho Turnpike, Jericho, NY 11753 (the “Investor”).
EQUITY FINANCING AGREEMENTEquity Financing Agreement • September 14th, 2018 • Sunshine Biopharma, Inc • Services-commercial physical & biological research • Nevada
This EQUITY FINANCING AGREEMENT (the “Agreement”), dated as of September 10, 2018 (the “Execution Date”), is entered into by and between Sunshine Biopharma, Inc., a Colorado corporation with its principal executive office at 6500 Trans-Canada Highway, 4th Floor, Pointe-Claire, Quebec, Canada H9R 0A5 (the “Company”), and GHS Investments LLC, a Nevada limited liability company, with offices at 420 Jericho Turnpike, Suite 207, Jericho, NY 11753 (the “Investor”).
